Indication

Pathological gastric acid hypersecretory condition

A pathological gastric acid hypersecretory condition is a clinical disorder characterized by chronic, autonomous overproduction of gastric acid that substantially exceeds normal physiological requirements. Read more about Pathological gastric acid hypersecretory condition

502 drugs 204 manufacturers

Advertisement

Drugs that treat it

Common Pathological gastric acid hypersecretory condition therapies.

Showing 217–225 of 502 drugs

OMEPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+10
NORTHSTAR RX LL

LANSOPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
TEVA USA
Filter & compare in the drug finder →Opens the drug finder with Pathological gastric acid hypersecretory condition preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pathological gastric acid hypersecretory condition.

A pathological gastric acid hypersecretory condition is a clinical disorder characterized by chronic, autonomous overproduction of gastric acid that substantially exceeds normal physiological requirements.

Primarily affecting the upper gastrointestinal tract, these conditions most commonly arise from underlying neuroendocrine or systemic disorders, such as gastrin-secreting neuroendocrine tumors in Zollinger-Ellison syndrome, systemic mastocytosis with hyperhistaminemia, or idiopathic gastric acid hypersecretion.

Pathophysiologically, persistent hyperstimulation of gastric parietal cells leads to severe hyperchlorhydria, which frequently manifests as refractory or recurrent peptic ulcer disease, severe erosive esophagitis, gastrointestinal bleeding, and secretory diarrhea.

Personalize your experience

Follow Pathological gastric acid hypersecretory condition and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it